Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marshall Posner

Showing results (21-30 of 91) with videos related to

Pageof 10
Sort By:
The Oncologist|January 25, 2013
A patient-centered approach to counseling patients with head and neck cancer undergoing human papillomavirus testing: a clinician's guideAmy Chu, Eric Genden, Marshall Posner, et al.
Advances in Experimental Medicine and Biology|May 14, 2014
The role of inflammation in head and neck cancerMarcelo Bonomi, Alexis Patsias, Marshall Posner, et al.
Anti-Cancer Drugs|February 19, 2014
Taxanes in cancer of the head and neckKrzysztof Misiukiewicz, Vishal Gupta, Richard Bakst, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2009
Decreased EBNA-1-specific CD8+ T cells in patients with Epstein-Barr virus-associated nasopharyngeal carcinomaMark H Fogg, Lori J Wirth, Marshall Posner, et al.
The Oncologist|May 16, 2025
Navigating challenging patient factors in systemic therapy for head and neck cancerPetr Szturz, Robert I Haddad, Marshall Posner, et al.
Seminars in Oncology|January 17, 2004
Phase II randomized study of concomitant chemoradiation using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with newly diagnosed locally advanced squamous cell carcinoma of the head and neckRobert Haddad, Lori Wirth, Rosemary Costello, et al.
The Oncologist|May 25, 2012
Squamous cell carcinoma of the oral tongue in two patients previously exposed to long-term pegylated liposomal doxorubicinMarcelo R Bonomi, Krzysztof Misiukiewicz, Marshall Posner, et al.
Expert Review of Anticancer Therapy|February 1, 2006
Integrating novel agents into the curative treatment of head and neck cancerRobert Haddad, Aaron Allen, Lori Wirth, et al.
The Mount Sinai Journal of Medicine, New York|November 25, 2010
Head and neck squamous cell carcinoma: new translational therapiesAnthony Prince, Julio Aguirre-Ghizo, Eric Genden, et al.
Virology|April 23, 2013
Therapeutic targeting of regulatory T cells enhances tumor-specific CD8+ T cell responses in Epstein-Barr virus associated nasopharyngeal carcinomaMark Fogg, John R Murphy, Jochen Lorch, et al.
Pageof 10

Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
The Oncologist|January 25, 2013
A patient-centered approach to counseling patients with head and neck cancer undergoing human papillomavirus testing: a clinician's guideAmy Chu, Eric Genden, Marshall Posner, et al.
Advances in Experimental Medicine and Biology|May 14, 2014
The role of inflammation in head and neck cancerMarcelo Bonomi, Alexis Patsias, Marshall Posner, et al.
Anti-Cancer Drugs|February 19, 2014
Taxanes in cancer of the head and neckKrzysztof Misiukiewicz, Vishal Gupta, Richard Bakst, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2009
Decreased EBNA-1-specific CD8+ T cells in patients with Epstein-Barr virus-associated nasopharyngeal carcinomaMark H Fogg, Lori J Wirth, Marshall Posner, et al.
The Oncologist|May 16, 2025
Navigating challenging patient factors in systemic therapy for head and neck cancerPetr Szturz, Robert I Haddad, Marshall Posner, et al.
Seminars in Oncology|January 17, 2004
Phase II randomized study of concomitant chemoradiation using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with newly diagnosed locally advanced squamous cell carcinoma of the head and neckRobert Haddad, Lori Wirth, Rosemary Costello, et al.
The Oncologist|May 25, 2012
Squamous cell carcinoma of the oral tongue in two patients previously exposed to long-term pegylated liposomal doxorubicinMarcelo R Bonomi, Krzysztof Misiukiewicz, Marshall Posner, et al.
Expert Review of Anticancer Therapy|February 1, 2006
Integrating novel agents into the curative treatment of head and neck cancerRobert Haddad, Aaron Allen, Lori Wirth, et al.
The Mount Sinai Journal of Medicine, New York|November 25, 2010
Head and neck squamous cell carcinoma: new translational therapiesAnthony Prince, Julio Aguirre-Ghizo, Eric Genden, et al.
Virology|April 23, 2013
Therapeutic targeting of regulatory T cells enhances tumor-specific CD8+ T cell responses in Epstein-Barr virus associated nasopharyngeal carcinomaMark Fogg, John R Murphy, Jochen Lorch, et al.
Pageof 10